Sort
50,496 grants matching “lung cancer”
MODERATE EXERCISE TO AID SMOKING CESSATION IN WOMEN
$434,731Miriam Hospital · R01 · FY2000 · CA
Comprehensive molecular characterization of lung cancers in five racial/ethnic groups with disparate risk
$434,691Sungshim Lani Park · University Of Hawaii At Manoa · R01 · FY2024 · MD
Transport of Effector T cells and Nano-DC vaccine in Breast Cancer
$434,685Elizabeth Mittendorf · Methodist Hospital Research Institute · U54 · FY2017 · CA
SCH: INT: Harnessing the Power of Technology: MOMBA for Postpartum Smoking
$434,652Megan Veenema Smith · Yale University · R01 · FY2014 · CA
Project 3: Multispectral Imaging and Robotic Bronchoscopy Devices for Precision Lung Tumor Detection
$434,647Shuming Nie · University Of Pennsylvania · P01 · FY2022 · CA
Clinical production of viral vectors for cancer gene therapy
$434,646Rachel Beyer · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA
A novel preclinical model of spontaneous metastasis
$434,638Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Enhancing neutrophil function in neutropenia-related pneumonia
$434,631Hongbo R Luo · Boston Children'S Hospital · R01 · FY2015 · HL
Role of GAS41 in Human Cancer
$434,625Xiaobing Shi · Van Andel Research Institute · R01 · FY2020 · CA
High Throughput Screen for Inhibitors of the YEATS2 Histone Acylation Reader
$434,625Xiaobing Shi · Van Andel Research Institute · R01 · FY2025 · CA
Effect of the aged microenvironment on tumor dormancy
$434,625Ashani T Weeraratna · Wistar Institute · R01 · FY2017 · CA
Tumor Cell Dependence on Host Metabolism
$434,619Eileen White · Rutgers, The State Univ Of N.J. · R01 · FY2019 · CA
Imaging Habitats in Sarcoma
$434,604Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2019 · CA
Integrated Chemoselective and Informatic Platform for Large-Scale Metabolomics
$434,596Teresa W-M Fan · University Of Kentucky · R01 · FY2013 · ES
NKX2-1, A Candidate Lineage Survival Oncogene in Lung Adenocarcinoma
$434,583Matthew L Meyerson · Dana-Farber Cancer Inst · R01 · FY2010 · CA
High-Throughput Evaluation of Breast Cancer Markers
$434,557Richard C Zangar · Battelle Pacific Northwest Laboratories · U01 · FY2007 · CA
Targeting LSD1 to prevent therapy-induced transdifferentiation in BRAF mutant colorectal cancer
$434,552Heather M O'Hagan · Indiana University Indianapolis · R01 · FY2025 · CA
Precision lung cancer therapy design through multiplexed adapter measurement
$434,529Aaron Samuel Meyer · University Of California Los Angeles · U01 · FY2020 · CA
Inhibition of P13k and MEK Pathways in the Treatment of Lung Cancer
$434,462Kwok Kin Wong · Dana-Farber Cancer Inst · R01 · FY2009 · CA
Regulation of lung cancer growth and metastasis by an actionable driver of vesicle biogenesis in the Golgi
$434,457Jonathan M Kurie · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Identifying the Impact of SETD2 Inactivation in Lung Adenocarcinoma
$434,444David Feldser · University Of Pennsylvania · R01 · FY2025 · CA
Neuroimmune Molecules in Scleroderma Lung Fibrosis
$434,436Erica L Herzog · Yale University · R01 · FY2016 · HL
In Vivo Studies of the Epileptic Hippocampus
$434,362Jerome None Engel · University Of California Los Angeles · R01 · FY2015 · NS
Dissecting and Targeting MAST1 Signaling in chemoresistant Cancers
$434,313Sumin Kang · Emory University · R01 · FY2024 · CA
Dissecting and Targeting MAST1 Signaling in chemoresistant Cancers
$434,313Sumin Kang · Emory University · R01 · FY2025 · CA